Tag: prostate adenocarcinoma

#VisualAbstract: Continued enzalutamide after progression of metastatic prostate cancer improves progression-free survival

byMinjee Kim

October 26, 2022

1. The median progression-free survival was higher in the enzalutamide vs the placebo group (9.5 months vs 8.3 months) 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Therapeutic-dose anticoagulation reduces mortality risk compared with prophylactic-dose anticoagulation in patients hospitalized for COVID-19
Radiofrequency Ablation vs Stereotactic Body Radiotherapy for Recurrent HCC
#VisualAbstract: Tezepelumab Does Not Reduce Exacerbations in Adults with Chronic Obstructive Pulmonary Disease

No Result

View All Result